{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:48:04Z","timestamp":1761562084152,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.carrev.2016.08.010","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T12:17:19Z","timestamp":1473423439000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study"],"prefix":"10.1016","volume":"18","author":[{"given":"Kohki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Giacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ortega-Paz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Shiratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Mart\u00edn-Yuste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Masotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Brugaletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2016.08.010_bb0005","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/eurheartj\/ehq066","article-title":"The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study","volume":"31","author":"Ozaki","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.08.010_bb0010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jacc.2014.01.019","article-title":"Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition","volume":"63","author":"Attizzani","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.08.010_bb0015","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.106.658237","article-title":"Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.08.010_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2011.09.018","article-title":"Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging","volume":"5","author":"Guagliumi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"20-9","key":"10.1016\/j.carrev.2016.08.010_bb0025","first-page":"S1","article-title":"Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography","volume":"5","author":"Gutierrez-Chico","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"Suppl. D","key":"10.1016\/j.carrev.2016.08.010_bb0030","first-page":"D112","article-title":"Late acquired incomplete stent apposition: incidence, mechanisms and clinical implications","volume":"5","author":"de la Torre Hernandez","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2016.08.010_bb0035","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehn553","article-title":"Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis","volume":"31","author":"Hassan","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.08.010_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2011.10.102","article-title":"Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents","volume":"166","author":"Takano","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.08.010_bb0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4244\/EIJV11I5A109","article-title":"Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial","volume":"11","author":"Kubo","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2016.08.010_bb0050","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"Raber","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.08.010_bb0055","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.08.010_bb0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- Versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.08.010_bb0065","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.08.010_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2016.08.010_bb0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jcin.2007.12.007","article-title":"In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation","volume":"1","author":"Suzuki","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.08.010_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.carrev.2016.02.006","article-title":"Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study","volume":"17","author":"Otsuki","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"issue":"35","key":"10.1016\/j.carrev.2016.08.010_bb0085","first-page":"2541","article-title":"ESC\/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution o","volume":"2014","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2016.08.010_bb0090","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jcin.2011.03.020","article-title":"Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography","volume":"4","author":"Gomez-Lara","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.08.010_bb0095","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2008.05.069","article-title":"The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography","volume":"134","author":"Tanigawa","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2016.08.010_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2012.08.037","article-title":"Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography","volume":"111","author":"Kim","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2016.08.010_bb0105","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00380-015-0737-2","article-title":"Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3months after 2nd-generation drug-eluting stent implantation","volume":"31","author":"Izumi","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.carrev.2016.08.010_bb0110","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/ehjci\/jes299","article-title":"Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up","author":"Kawamori","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2016.08.010_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjci\/jeu174","article-title":"Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis","volume":"16","author":"Shimamura","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2016.08.010_bb0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcin.2010.02.008","article-title":"Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents","volume":"3","author":"Guagliumi","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.08.010_bb0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1253\/circj.CJ-09-0546","article-title":"Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9months after implantation","volume":"74","author":"Lee","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2016.08.010_bb0130","first-page":"724","article-title":"Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial","author":"Yamasaki","year":"2012","journal-title":"Euro Intervention"},{"key":"10.1016\/j.carrev.2016.08.010_bb0135","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1year after percutaneous coronary intervention","volume":"02115","author":"Yeh","year":"2016","journal-title":"JAMA"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916302329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916302329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:12:02Z","timestamp":1761559922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838916302329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1553838916302329"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2016.08.010","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial optical coherence tomography assessment of malapposed struts after everolimus-eluting stent implantation. A subanalysis from the HEAL-EES study","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2016.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}